Treatment of cholestatic pruritus in children / | Cies, Jeffrey J. ;, Giamalis, John N. | 1157-1162 | 2007.06.20 | - | |
Resumption of high-dose methotrexate after methotrexate-induced nephrotoxicity and carboxypeptidase G2 use / | Snyder, Ronald L. | 1163-1169 | 2007.06.20 | - | |
Educational interventions to reduce use of unsafe abbreviations / | Abushaiqa, Mohammed E. et al | 1170-1173 | 2007.06.20 | - | |
Evidence-based review of the black-box warning for droperidol / | Jackson, Cherry W. ;, Sheehan, Amy Heck ;, Reddan, Jennifer G. | 1174-1186 | 2007.06.20 | - | |
Valsartan versus lisinopril or extended-release metoprolol in preventing cardiovascular and renal events in patients with hypertension / | Delea, Thomas E. et al | 1187-1196 | 2007.06.20 | - | |
Internal reporting system to improve a pharmacy’s medication distribution process / | Rickrode, Geoffrey A. et al | 1197-1202 | 2007.06.20 | - | |
Survey of hospitals for guidelines, policies, and protocols for anticoagulants / | Vats, Vikrant. et al | 1203-1208 | 2007.06.20 | - | |
Physical and chemical stability of palonosetron hydrochloride with five opiate agonists during simulated Y-site administration / | Trissel, Lawrence A. et al | 1209-01213 | 2007.06.20 | - | |